Prospective Study of White Blood Cells

Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04838171

Enrollment

Registered

2021-04-08

Start date

2021-03-24

Completion date

2030-01-01

Last updated

2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Diseases, Inflammation, Rejection; Transplant, Liver

Brief summary

The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.

Interventions

OTHERWhite blood cell and blood collection

Mononucleocytes will be collected via apheresis

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

No additional inclusion/

Exclusion criteria

will be applied by Quell other than those specified by the consenting institutions.

Design outcomes

Primary

Measure	Time frame	Description
WBC characterisation to support the development of engineered regulatory T cells.	5 years	number, type and function of white blood cells in healthy controls and in patients

Countries

United Kingdom

Contacts

CONTACTGareth Wright

contact@quell-tx.com+4(0)2070969012

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026